Abstract
Colorectal cancer (CRC) is one of the most difficult cancers to cure. An important prognostic factor is metastasis, which precludes curative surgical resection. Recent evidences show that Evodiamine (EVO) exerts an inhibitory effect on cancer cell apoptosis, migration, and invasion. In this study, we investigated the effects of EVO on the metastasis of CRC cells in vitro and in vivo. In vitro, wound-healing and transwell assay showed that migration and invasion of HT-29 and HCT-116 CRC cells were inhibited significantly by EVO. Western blot and RT-PCR showed that EVO reduced the expression of matrix metalloproteinase-9 in a dose-dependent manner. In EVO-induced cells, the intracellular NAD+/NADH ratio was increased, the level of Sirt1 was increased, and acetyl-NF-κB P65 was decreased. This process was inhibited by nicotinamide, an inhibitor of Sirt1. In vivo, EVO reduced tumor metastasis markedly. These findings provide evidences that EVO suppresses the migration and invasion of CRC cells by inhibiting the acetyl-NF-κB p65 by Sirt1, resulting in suppression of metalloproteinase-9 expression in vitro and in vivo.
References
Feb 29, 2000·Nature·S ImaiL Guarente
Nov 29, 2002·The EMBO Journal·Lin-feng ChenWarner C Greene
Mar 7, 2003·Molecular Cell·Brian J NorthEric Verdin
Feb 21, 2004·Science·Anne BrunetMichael E Greenberg
May 21, 2004·The EMBO Journal·Fan YeungMarty W Mayo
Feb 16, 2005·The Journal of Biological Chemistry·Yasunari TakadaBharat B Aggarwal
Mar 7, 2007·Journal of Cellular Biochemistry·Shu-Fen KanPaulus S Wang
Oct 30, 2007·Molecular Cell·Eun-Joo KimSoo-Jong Um
May 20, 2008·Free Radical Research·Jia YangTakashi Ikejima
Oct 8, 2008·Cell Cycle·Jack FordJo Milner
Feb 26, 2009·Journal of Cellular Biochemistry·Sook-Kyoung HeoSun-Dong Park
Jun 25, 2009·Chemistry & Biodiversity·Zhi-Gang YangBo Liu
May 8, 2010·Free Radical Research·Jia YangTakashi Ikejima
Jun 10, 2011·The New England Journal of Medicine·Leonard Guarente
Jul 30, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Wen-Fei ChiouBai-Luh Wei
Dec 14, 2011·The Journal of Endocrinology·R L MooreD V Faller
Jun 25, 2014·PloS One·Chih-Chiang ChienYen-Chou Chen
May 26, 2015·Human Pathology·Yul Ri ChungHan Suk Ryu
Jun 30, 2015·PloS One·Liane M McGlynnPaul G Shiels
Aug 15, 2015·Biochimie·Anuradha PandeyAnil Bhanudas Gaikwad
Nov 22, 2015·Journal of Cellular Biochemistry·Hua SuiQi Li
Jan 7, 2016·Frontiers in Molecular Neuroscience·Ruey-Horng ShihChuen-Mao Yang
Feb 20, 2016·Oncology Letters·Deng-Feng YuYong-Zhi Lun
Feb 24, 2016·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Tze-Chien ChenYen-Chou Chen
May 14, 2016·Molecular Medicine Reports·Chengqi HuJing Wang
May 15, 2016·Bioorganic & Medicinal Chemistry·Nan ZhaoHui-Ming Hua
Aug 4, 2016·Molecular Medicine Reports·Li LinJin Qi
Apr 19, 2017·Molecular Oncology·Sunbin LingShusen Zheng
Apr 19, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Fatema Al-RashedRasheed Ahmad
Dec 5, 2017·Critical Reviews in Oncology/hematology·Sam TilborghsPeter A van Dam
Jan 6, 2018·BMC Cancer·Farshad FarshidfarOliver F Bathe
Jan 9, 2018·International Journal of Biological Macromolecules·Mohammad RaishNaushad Ali
Citations
Feb 20, 2020·Clinical and Experimental Pharmacology & Physiology·Eman F KhaleelDalia G Mostafa
Jul 31, 2019·Naunyn-Schmiedeberg's Archives of Pharmacology·Hanzhang ZhuChangku Jia
Dec 15, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hyejin KimWoo-Young Kim
Apr 13, 2020·Cellular and Molecular Neurobiology·Tianyu MengDianfeng Liu
Apr 12, 2019·Frontiers in Pharmacology·Chen-Guang LiDong-Yun Ouyang
Aug 11, 2020·American Journal of Physiology. Endocrinology and Metabolism·Qintuo PanLili Li
Dec 31, 2019·Seminars in Cancer Biology·Thomas Efferth, Franz Oesch
Jan 5, 2021·Anti-cancer Drugs·Di ZengJing Li
Aug 2, 2020·Journal of Ethnopharmacology·Qiang SunXiaofang Li
Oct 12, 2021·Experimental and Therapeutic Medicine·Chaodan LuoXiaojie Luo